Posts

Showing posts with the label Mucopolysaccharidosis (MPS) Treatment

Stem cell technology is emerging as one of the Mucopolysaccharidosis (MPS) treatment

Image
  Mucopolysaccharides are more popularly known are long linear, non-repetitious polysaccharide units containing at least one non-lactose sugar with an attached galactose sugar. The repeating two-dimensional sugar unit is composed of amino acid and uric acid, excluding mucopolysaccharides, where in place of the amino acid it contains galactose; the non-galactose sugar, on the other hand, is either glucose or galactose. Mucopolysaccharides are produced in the intestines through a series of events. First, the ingested food supplies the enzymes required for glycolysis, the process that produces energy from glucose. Glucose is transported to the liver for conversion into glycogen, a material that stores fat and prevents glycolysis from being inhibited. The liver then transports the glycogen back to the small intestine where it is incorporated into long chains of glucose-free glucose and transported back into the bloodstream. These long chains eventually exit the body in the urine. M...